Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), GE Aerospace ...

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

Vertex Pharmaceuticals has solid revenue projections for its CF franchise, and a promising drug pipeline, especially in pain.

Around 13 percent of American adults regularly take an antidepressant, according to 2020 data, the most common of which are ...

Shares of telehealth provider Hims & Hers Health Inc. (HIMS) dropped over 3% on Thursday after Cigna Group’s (CI) Evernorth ...

The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...

Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...

Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss ...

Breed’s Hill Capital LLC more than tripled its stake in Eli Lilly during Q4, gobbling up 1,426 shares and pushing the company ...

ETFs that track dividend growth can deliver solid capital appreciation with reduced volatility for investors wary of the S&P ...

For a limited time, Wegovy will be available to new patients at $199 for the first month, Novo Nordisk said Thursday.